US 11591336
Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11591336 (Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors) held by Relay Therapeutics, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K45/06, A61P, A61P19/06, A61P3/00